Horan Securities, Inc. Eli Lilly & CO Transaction History

Horan Securities, Inc.

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Jul 27, 2023	BUY	$350.74 - $468.98 $350 - $468	1 Added 0.55%	182 $85,000
Q1 2023 Apr 18, 2023	SELL	$310.63 - $364.82 $9,318 - $10,944	-30 Reduced 14.22%	181 $62,000
Q4 2022 Jan 17, 2023	BUY	$321.55 - $374.67 $52,091 - $60,696	162 Added 330.61%	211 $0
Q3 2022 Oct 12, 2022	SELL	$296.48 - $337.87 $14,527 - $16,555	-49 Reduced 50.0%	49 $16,000
Q2 2022 Jul 19, 2022	BUY	$278.73 - $327.27 $13,379 - $15,708	48 Added 96.0%	98 $32,000
Q1 2022 May 10, 2022	BUY	$234.69 - $291.66 $234 - $291	1 Added 2.04%	50 $14,000
Q4 2021 Feb 09, 2022	BUY	$224.85 - $279.04 $4,497 - $5,580	20 Added 68.97%	49 $14,000
Q1 2021 May 14, 2021	BUY	$164.32 - $212.72 $2,136 - $2,765	13 Added 81.25%	29 $5,000
Q4 2020 Feb 05, 2021	SELL	$130.46 - $172.63 $1,826 - $2,416	-14 Reduced 46.67%	16 $3,000
Q3 2020 Nov 04, 2020	BUY	$146.22 - $169.13 $4,386 - $5,073	30 New	30 $4,000

4,011

751M

8.27M

10.5M

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $756B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

Get notified when there are updates to the investment portfolio of Horan Securities, Inc., based on Form 13F filings with the SEC.

Stay updated on Horan Securities, Inc. with notifications on news.